<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">INTERFERON BETA-1a</span><br/>(in-ter-fer'on)<br/><span class="topboxtradename">Avonex, </span><span class="topboxtradename">Rebif<br/></span><b>Classifications:</b> <span class="classification"> immunomodulator</span>; <span class="classification">interferon</span><br/><b>Prototype: </b>Interferon alfa-2a<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>
<b>Avonex</b> 33 mcg vial; 30 mcg/5 mL prefilled syringe; 
         				<b>Rebif</b> 22 mcg, 44 mcg vial
      </p>
<h1><a name="action">Actions</a></h1>
<p>Interferon beta-1a is produced by recombinant DNA technology. Interferon beta exerts its biological effects by binding to
         specific receptors on the surface of human cells.
      </p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>The mechanisms by which interferon beta-1a exerts its effect on multiple sclerosis is not fully defined; however, time of
         onset of progression in disability was significantly longer in patients treated with interferon beta-1a.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Relapsing-remitting multiple sclerosis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Previous hypersensitivity to interferon beta or human albumin, pregnancy (category C) but may cause a spontaneous abortion,
         lactation.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Suicidal tendencies, depression, preexisting psychiatric disorders; hepatic impairment. Safety and efficacy in children 
      </p><h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Multiple Sclerosis</span><br/><span class="rdage">Adult:</span> <span class="rdroute">IM</span>
<b>Avonex</b> 30 mcg qwk <span class="rdroute">SC</span>
<b>Rebif</b> 44 mcg 3 times/wk<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Intramuscular</span><br/><ul>
<li>Avonex: Reconstitute single use Avonex vial (33 mcg of lyophilized powder) with 1.1 mL of supplied diluent and swirl gently
            to dissolve. Withdraw 1.0 mL for administration. Discard any residual drug as the product contains no preservatives.
         </li>
<li>Use within 6 h of reconstitution.</li>
</ul><span class="adminroutetype">Subcutaneous</span><br/><ul>
<li>Rebif: Give at the same time each day (preferably in the late afternoon or evening) on the same three days of the week at
            least 48 h apart each week. Dose is usually titrated up from 8.8 mcg to 44 mcg three times a week over a four-week period.
         </li>
<li>Inject SC using either a 22 or 44 mcg prefilled syringe. Discard any residual drug as the product contains no preservatives.</li>
<li>Store unreconstituted vials or prefilled syringes at 2°8° C (36°46° F). May store for <img src="../images/special/lesserorequal.gif"/>30 d at room temperature up to 25° C (77° F). Do not use beyond expiration
            date.
         </li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Alopecia, myalgias, <span class="speceff-common">flu-like syndrome,</span> anaphylaxis. <span class="typehead">CNS:</span> Headache, <span class="speceff-common">fever,</span> fatigue, lethargy, depression, somnolence, weakness, agitation, malaise, confusion or reduced ability to concentrate, anxiety,
      dementia, emotional lability, depersonalization, suicide attempts, worsening of psychiatric disorders. <span class="typehead">CV:</span> Tachycardia, CHF (rare). <span class="typehead">GI:</span> Nausea, vomiting, <span class="speceff-common">diarrhea, hepatic injury.</span>
<span class="typehead">Hematologic:</span>
<span class="speceff-common">Leukopenia, thrombocytopenia,</span> anemia, pancytopenia (rare), thrombocytopenia (rare). <span class="typehead">Metabolic:</span> Hypocalcemia, elevated serum creatinine, elevated liver transaminases. <span class="typehead">Skin:</span> Local skin necrosis at injection site, <span class="speceff-common">pain at injection site.</span>
<h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Peak:</span>
<b>Avonex</b> 7.89.8 h; <b>Rebif</b> 16 h. <span class="typehead">Metabolism:</span> Rapidly inactivated in body fluids and tissue. <span class="typehead">Half-Life:</span>
<b>Avonex</b> 8.610 h; <b>Rebif</b> 69 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Withhold drug and notify physician if depression or suicidal ideation develops or if there is a worsening of psychiatric symptoms.</li>
<li>Monitor patients with cardiac disease carefully for worsening cardiac function.</li>
<li>Lab tests: Monitor periodically liver function tests, renal function tests, routine blood chemistry, and CBC with differential,
            and platelet count. Monitor thyroid function tests q6mo with preexisting thyroid dysfunction or when clinically indicated.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take a missed dose as soon as possible but not within 48 h of next scheduled dose.</li>
<li>Learn about common adverse effects, especially flu-like syndrome (headache, fatigue, fever, rigors, chest pain, back pain,
            myalgia).
         </li>
<li>Withhold drug and notify physician of depression or suicidal ideation or exacerbation of a preexisting seizure disorder.</li>
<li>
            							Note: Women who wish to become pregnant must discontinue therapy.
            						
         </li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>